Literature DB >> 19903896

ALK1 signaling regulates early postnatal lymphatic vessel development.

Kyle Niessen1, Gu Zhang, John Brady Ridgway, Hao Chen, Minhong Yan.   

Abstract

In vertebrates, endothelial cells form 2 hierarchical tubular networks, the blood vessels and the lymphatic vessels. Despite the difference in their structure and function and genetic programs that dictate their morphogenesis, common signaling pathways have been recognized that regulate both vascular systems. ALK1 is a member of the transforming growth factor-beta type I family of receptors, and compelling genetic evidence suggests its essential role in regulating blood vascular development. Here we report that ALK1 signaling is intimately involved in lymphatic development. Lymphatic endothelial cells express key components of the ALK1 pathway and respond robustly to ALK1 ligand stimulation in vitro. Blockade of ALK1 signaling results in defective lymphatic development in multiple organs of neonatal mice. We find that ALK1 signaling regulates the differentiation of lymphatic endothelial cells to influence the lymphatic vascular development and remodeling. Furthermore, simultaneous inhibition of ALK1 pathway increases apoptosis in lymphatic vessels caused by blockade of VEGFR3 signaling. Thus, our study reveals a novel aspect of ALK1 signaling in regulating lymphatic development and suggests that targeting ALK1 pathway might provide additional control of lymphangiogenesis in human diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903896      PMCID: PMC2830767          DOI: 10.1182/blood-2009-07-235655

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype.

Authors:  Jeffrey T Wigle; Natasha Harvey; Michael Detmar; Irina Lagutina; Gerard Grosveld; Michael D Gunn; David G Jackson; Guillermo Oliver
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

2.  Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate.

Authors:  Young-Kwon Hong; Natasha Harvey; Yun-Hee Noh; Vivien Schacht; Satoshi Hirakawa; Michael Detmar; Guillermo Oliver
Journal:  Dev Dyn       Date:  2002-11       Impact factor: 3.780

Review 3.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

4.  Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

Authors:  Nicholas W Gale; Gavin Thurston; Sean F Hackett; Roumiana Renard; Quan Wang; Joyce McClain; Cliff Martin; Charles Witte; Marlys H Witte; David Jackson; Chitra Suri; Peter A Campochiaro; Stanley J Wiegand; George D Yancopoulos
Journal:  Dev Cell       Date:  2002-09       Impact factor: 12.270

5.  BMP type II receptor is required for gastrulation and early development of mouse embryos.

Authors:  H Beppu; M Kawabata; T Hamamoto; A Chytil; O Minowa; T Noda; K Miyazono
Journal:  Dev Biol       Date:  2000-05-01       Impact factor: 3.582

6.  Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

Authors:  Z Deng; J H Morse; S L Slager; N Cuervo; K J Moore; G Venetos; S Kalachikov; E Cayanis; S G Fischer; R J Barst; S E Hodge; J A Knowles
Journal:  Am J Hum Genet       Date:  2000-07-20       Impact factor: 11.025

7.  Arteriovenous malformations in mice lacking activin receptor-like kinase-1.

Authors:  L D Urness; L K Sorensen; D Y Li
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

8.  Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Authors:  T Mäkinen; L Jussila; T Veikkola; T Karpanen; M I Kettunen; K J Pulkkanen; R Kauppinen; D G Jackson; H Kubo; S Nishikawa; S Ylä-Herttuala; K Alitalo
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

9.  BMP signaling is required for septation of the outflow tract of the mammalian heart.

Authors:  Emmanuèle C Délot; Matthew E Bahamonde; Manxu Zhao; Karen M Lyons
Journal:  Development       Date:  2003-01       Impact factor: 6.868

10.  Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.

Authors:  Paul D Upton; Rachel J Davies; Richard C Trembath; Nicholas W Morrell
Journal:  J Biol Chem       Date:  2009-04-14       Impact factor: 5.157

View more
  39 in total

Review 1.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

2.  BMP-9 balances endothelial cell fate.

Authors:  Rik Derynck; Rosemary J Akhurst
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-12       Impact factor: 11.205

3.  Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function.

Authors:  Max M Gong; Karina M Lugo-Cintron; Bridget R White; Sheena C Kerr; Paul M Harari; David J Beebe
Journal:  Biomaterials       Date:  2019-05-25       Impact factor: 12.479

4.  ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway.

Authors:  Bruno Larrivée; Claudia Prahst; Emma Gordon; Raquel del Toro; Thomas Mathivet; Antonio Duarte; Michael Simons; Anne Eichmann
Journal:  Dev Cell       Date:  2012-03-13       Impact factor: 12.270

Review 5.  Development of the mammalian lymphatic vasculature.

Authors:  Ying Yang; Guillermo Oliver
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

Review 6.  Bone Morphogenetic Proteins.

Authors:  Takenobu Katagiri; Tetsuro Watabe
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-06-01       Impact factor: 10.005

7.  Reduced activin receptor-like kinase 1 activity promotes cardiac fibrosis in heart failure.

Authors:  Kevin J Morine; Xiaoying Qiao; Vikram Paruchuri; Mark J Aronovitz; Emily E Mackey; Lyanne Buiten; Jonathan Levine; Keshan Ughreja; Prerna Nepali; Robert M Blanton; S Paul Oh; Richard H Karas; Navin K Kapur
Journal:  Cardiovasc Pathol       Date:  2017-07-18       Impact factor: 2.185

8.  BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.

Authors:  Marie Bidart; Nicolas Ricard; Sandrine Levet; Michel Samson; Christine Mallet; Laurent David; Mariela Subileau; Emmanuelle Tillet; Jean-Jacques Feige; Sabine Bailly
Journal:  Cell Mol Life Sci       Date:  2011-06-28       Impact factor: 9.261

9.  Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation.

Authors:  Sandrine Levet; Delphine Ciais; Galina Merdzhanova; Christine Mallet; Teresa A Zimmers; Se-Jin Lee; Fabrice P Navarro; Isabelle Texier; Jean-Jacques Feige; Sabine Bailly; Daniel Vittet
Journal:  Blood       Date:  2013-06-05       Impact factor: 22.113

10.  Essential role for TMEM100 in vascular integrity but limited contributions to the pathogenesis of hereditary haemorrhagic telangiectasia.

Authors:  Eun-Hye Moon; Yoo Sung Kim; Jiyoung Seo; Sabin Lee; Young Jae Lee; Suk Paul Oh
Journal:  Cardiovasc Res       Date:  2014-12-23       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.